Results: 5

3.
Figure II

Figure II. From: A phase I trial using the proteasome inhibitor bortezomib and concurrent temozolomide and radiotherapy for CNS malignancies.

Radiation treatment dose and fractionation by histology

Gregory J. Kubicek, et al. Int J Radiat Oncol Biol Phys. ;74(2):433-439.
4.
Figure V

Figure V. From: A phase I trial using the proteasome inhibitor bortezomib and concurrent temozolomide and radiotherapy for CNS malignancies.

Kaplan-Meier survival by bortezomib dose

Gregory J. Kubicek, et al. Int J Radiat Oncol Biol Phys. ;74(2):433-439.
5.
Figure III

Figure III. From: A phase I trial using the proteasome inhibitor bortezomib and concurrent temozolomide and radiotherapy for CNS malignancies.

Example of brain MRI of patient with stable disease

Gregory J. Kubicek, et al. Int J Radiat Oncol Biol Phys. ;74(2):433-439.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk